Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome

doi:10.3748/wjg.v20.i37.13563

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 37

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8277)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

492

WORD

271

HTML

5175

Figures (1-2)

145

Tables (1-4)

164

Sum=6247

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

916

Download

1114

Sum=2030

Oct 7, 2014 (publication date) through Jul 19, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Oct 7, 2014; 20(37): 13563-13572
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13563

Table 2 Comparisons of the symptom scores for patients in each group at different stages of treatment

Group	n		Birmingham	IBS-QOL	SDS	SAS	HAMD	HAMA
Group 1	40	Before	21.10 ± 8.62	75.75 ± 21.72	45.33 ± 11.04	42.83 ± 9.62	6.13 ± 5.43	5.90 ± 5.22
		1^st course	11.60 ± 7.53^a	60.20 ± 14.82^a	36.20 ± 8.37^a	36.65 ± 9.37^a	3.75 ± 3.40^a	4.05 ± 3.57^a
		2^nd course	5.55 ± 5.05^a^b^c	50.65 ± 10.86^a^b	32.43 ± 6.94^a^b	32.08 ± 6.95^a^b	1.75 ± 2.31^a^b	2.23 ± 2.90^a^b
Group 2	40	Before	23.45 ± 8.25	75.38 ± 21.02	43.45 ± 13.93	43.10 ± 12.86	7.25 ± 7.06	6.68 ± 4.74
		1^st course	15.58 ± 9.15^a	59.40 ± 18.02^a	38.13 ± 10.54^a	37.35 ± 10.03^a	4.03 ± 3.28^a	3.28 ± 3.03^a
		2^nd course	10.45 ± 6.61^a^b	47.90 ± 10.49^a^b	32.53 ± 7.26^a^b	32.25 ± 7.14^a^b	1.98 ± 2.38^a^b	1.93 ± 2.14^a^b
Group 3	40	Before	21.50 ± 8.82	78.53 ± 24.22	46.80 ± 13.53	46.15 ± 12.74	9.05 ± 6.54	7.53 ± 5.37
		1^st course	13.03 ± 8.23^a	58.28 ± 13.39^a	38.40 ± 10.41^a	37.95 ± 8.65^a	4.60 ± 2.77^a	3.98 ± 2.30^a
		2^nd course	5.65 ± 4.00^a^b^c	48.83 ± 9.38^a^b	32.50 ± 7.95^a^b	33.70 ± 7.00^a^b	2.10 ± 1.95^a^b	2.20 ± 1.60^a^b
Group 4	40	Before	23.65 ± 7.62	76.88 ± 19.90	46.00 ± 12.59	44.38 ± 12.02	7.50 ± 7.66	6.63 ± 4.78
		1^st course	13.95 ± 7.69^a	60.00 ± 16.09^a	38.15 ± 9.76^a	37.23 ± 10.50^a	4.10 ± 4.89^a	3.68 ± 2.67^a
		2^nd course	8.38 ± 6.17^a^b	48.48 ± 13.87^a^b	32.38 ± 9.15^a^b	33.45 ± 8.73^a^b	1.90 ± 3.04^a^b	2.20 ± 2.39^a^b

Group 1: One cone of moxibustion per treatment, three treatments/wk; Group 2: One cone of moxibustion per treatment, six treatments/wk; Group 3: Two cones of moxibustion per treatment, three treatments/wk; Group 4: Two cones of moxibustion per treatment, six treatments/wk; Before: Before treatment; 1^st course: After the first course of treatment; 2^nd course: After the second course of treatment; Birmingham: Birmingham irritable bowel syndrome symptom questionnaire; IBS-QOL: Irritable bowel syndrome Quality of Life Scale; SDS: Self-Rating Depression Scale; SAS: Self-Rating Anxiety Scale; HAMD: Hamilton Depression Scale; HAMA: Hamilton Anxiety Scale. Compared with the first course after treatment;

^aP < 0.001 vs before treatment;

^bP < 0.001 vs the first course after treatment;

^cP < 0.001 vs group 2.

Citation: Zhao JM, Wu LY, Liu HR, Hu HY, Wang JY, Huang RJ, Shi Y, Tao SP, Gao Q, Zhou CL, Qi L, Ma XP, Wu HG. Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2014; 20(37): 13563-13572
URL: https://www.wjgnet.com/1007-9327/full/v20/i37/13563.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i37.13563